MedTrace Logo

Medical Expulsive Therapy Post-SWL For Renal Stones

NCT05032287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2021-09-02

No results posted yet for this study

Summary

To evaluate the efficacy and stone free rate of placebo versus tamsulosin as medical expulsive therapy post-SWL in patients with renal stone less than 20 mm

Conditions

  • Urologic Diseases
  • Urolithiasis
  • Stone, Kidney

Interventions

DRUG

Tamsulosin

Tamsulosin 0.4 mg once daily

DRUG

Placebo

Placebo once daily

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-05-01
Completion
2020-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05032287 on ClinicalTrials.gov